Squarepoint
ARVN icon

Squarepoint’s Arvinas ARVN Stock Holding History

Squarepoint’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
201,822
+178,362
+760% +$1.66M ﹤0.01% 2479
2026
Q1 		$249K Buy
+23,460
New +$291K ﹤0.01% 3838
2025
Q2 		– Sell
-137,263
Closed -$1.01M – 4467
2025
Q1 		$964K Buy
137,263
+120,674
+727% +$1.89M ﹤0.01% 2703
2024
Q4 		$318K Sell
16,589
-153,259
-90% -$3.72M ﹤0.01% 4101
2024
Q3 		$4.18M Buy
169,848
+50,949
+43% +$1.33M 0.01% 1534
2024
Q2 		$3.17M Buy
118,899
+37,028
+45% +$1.18M 0.01% 1701
2024
Q1 		$3.38M Buy
81,871
+75,269
+1,140% +$3.29M 0.01% 1739
2023
Q4 		$272K Sell
6,602
-42,436
-87% -$992K ﹤0.01% 3432
2023
Q3 		$963K Sell
49,038
-40,250
-45% -$987K ﹤0.01% 2348
2023
Q2 		$2.22M Buy
89,288
+50,813
+132% +$1.31M 0.01% 1594
2023
Q1 		$1.05M Buy
+38,475
New +$1.22M ﹤0.01% 1859
2022
Q4 		– Sell
-37,989
Closed -$1.69M – 3163
2022
Q3 		$1.69M Sell
37,989
-37,598
-50% -$1.83M 0.01% 1426
2022
Q2 		$3.18M Buy
75,587
+47,047
+165% +$2.36M 0.02% 912
2022
Q1 		$1.92M Buy
28,540
+23,001
+415% +$1.57M 0.01% 1183
2021
Q4 		$455K Sell
5,539
-23,770
-81% -$1.93M ﹤0.01% 2196
2021
Q3 		$2.41M Buy
29,309
+10,453
+55% +$924K 0.01% 1115
2021
Q2 		$1.45M Buy
18,856
+4,252
+29% +$295K 0.01% 1373
2021
Q1 		$965K Sell
14,604
-13,540
-48% -$1.04M 0.01% 1528
2020
Q4 		$2.39M Sell
28,144
-46,117
-62% -$1.59M 0.02% 850
2020
Q3 		$1.75M Buy
74,261
+47,635
+179% +$1.38M 0.02% 697
2020
Q2 		$893K Buy
+26,626
New +$1.13M 0.01% 1004
2020
Q1 		– Sell
-16,646
Closed -$684K – 1846
2019
Q4 		$684K Sell
16,646
-8,967
-35% -$263K ﹤0.01% 1575
2019
Q3 		$552K Buy
+25,613
New +$629K ﹤0.01% 1567

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Squarepoint's ARVN Position: Q2 2026 in Review

Squarepoint increased its Arvinas (ARVN) stake by 760% in Q2 2026, buying an estimated $1.66M and bringing the position to 201,822 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2479.

Squarepoint first reported a position in ARVN in Q3 2019 and has held it in 23 quarters since. The position peaked at $4.18M in Q3 2024. 202 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Squarepoint held 201,822 shares of Arvinas worth $1.68M as of Q2 2026.
  • Squarepoint bought 178,362 Arvinas shares in Q2 2026, an estimated $1.66M.
  • Arvinas made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2479 holding.
  • Squarepoint first reported a position in Arvinas in Q3 2019 and has held it in 23 quarters since.
  • Squarepoint's Arvinas position peaked at $4.18M in Q3 2024.
  • 202 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.